Integrating PSA Change with PSA Density Enhances Diagnostic Accuracy and Helps Avoid Unnecessary Prostate Biopsies [PDF]
DiagnosticsBackground: Prostate-specific antigen (PSA) levels can be transiently elevated in benign conditions. Therefore, guidelines recommend repeat PSA testing before a biopsy.
Yi-Ju Chou, Bor-En Jong, Yao-Chou Tsai
doaj +5 more sources
PSA Density Help to Identify Patients With Elevated PSA Due to Prostate Cancer Rather Than Intraprostatic Inflammation: A Prospective Single Center Study [PDF]
Frontiers in Oncology, 2021 The association between PSA density, prostate cancer (PCa) and BPH is well established. The aim of the present study was to establish whether PSA density can be used as a reliable parameter to predict csPCa and to determine its optimal cutoff to exclude ...
Salvatore M. Bruno +16 more
doaj +4 more sources
Can the Gleason score be predicted in patients with prostate cancer? A dynamic contrast-enhanced MRI, (68)Ga-PSMA PET/CT, PSA, and PSA-density comparison study [PDF]
Diagnostic and Interventional Radiology, 2023 PURPOSEThe present study aims to evaluate whether perfusion parameters in prostate magnetic resonance imaging (MRI), (68)Ga-prostate-specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomography (CT), prostate-specific antigen ...
Hüseyin Akkaya +5 more
doaj +3 more sources
Post-SABR early PSA density kinetics in androgen deprivation therapy-naïve patients: early landmark models for long-term biochemical recurrence-free survival [PDF]
Clinical and Translational Radiation OncologyPurpose: To identify early post-treatment prostate-specific antigen density (PSAD) models associated with long-term biochemical recurrence-free survival (bRFS) after ultrahypofractionated prostate radiotherapy without androgen deprivation therapy (ADT),
Carlo Greco +8 more
doaj +2 more sources
Performance of prostate health index and PSA density in a diverse biopsy‐naïve cohort with mpMRI for detecting significant prostate cancer [PDF]
BJUI Compass, 2021 Objective To compare Prostate Health Index (PHI) and prostate‐specific antigen (PSA) density as secondary tests after multiparametric magnetic resonance imaging (mpMRI) in improving the detection accuracy of Gleason grade group (GG) 2‐5 prostate cancer ...
Samuel Carbunaru +16 more
doaj +2 more sources
Is PSA density of the peripheral zone as a useful predictor for prostate cancer in patients with gray zone PSA levels? [PDF]
BMC Cancer, 2021 Background Serum prostate-specific antigen (PSA) is widely used in screening tests for prostate cancer. As the low specificity of PSA results in unnecessary and invasive prostate biopsies, we evaluated the clinical significance of various PSAs and PSA ...
Jaegeun Lee +7 more
doaj +2 more sources
Peripheral zone PSA density: a predominant variable to improve prostate cancer detection efficiency in men with PSA higher than 4 ng ml-1 [PDF]
Asian Journal of Andrology, 2021 To improve the diagnostic efficiency of prostate cancer (PCa) and reduce unnecessary biopsies, we defined and analyzed the diagnostic efficiency of peripheral zone prostate-specific antigen (PSA) density (PZ-PSAD).
Cheng Wang +11 more
doaj +2 more sources
PSA density is associated with BPH cellular composition [PDF]
Prostate, 2022 Ryan Mauck, Douglas Strand, Liwei Jia
exaly +2 more sources
Comparison of Proclarix, PSA Density and MRI-ERSPC Risk Calculator to Select Patients for Prostate Biopsy after mpMRI [PDF]
Cancers, 2022 Lucas Regis +2 more
exaly +2 more sources
Evaluation of PSA and PSA Density in a Multiparametric Magnetic Resonance Imaging-Directed Diagnostic Pathway for Suspected Prostate Cancer: The INNOVATE Trial [PDF]
Cancers, 2021 Manuel Rodriguez-Justo +2 more
exaly +2 more sources